Litcius/Paper detail

Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants

Lucy Catteau, Nicolás Dauby, Marion Montourcy, Emmanuel Bottieau, Joris Hautekiet, Els Goetghebeur, Sabrina H. van Ierssel, Els Duysburgh, Herman Van Oyen, Chloé Wyndham-Thomas, Dominique Van Beckhoven, Kristof Bafort, Leïla Belkhir, Nathalie Bossuyt, Philippe Caprasse, Vincent Colombié, Paul De Munter, Jessika Deblonde, Didier Delmarcelle, Mélanie Delvallee, Rémy Demeester, Thierry Dugernier, Xavier Holemans, Benjamin Kerzmann, Pierre Yves Machurot, Philippe Minette, Jean-Marc Minon, Saphia Mokrane, Catherine Nachtergal, Séverine Noirhomme, Denis Piérard, Camélia Rossi, Carole Schirvel, Erica Sermijn, Frank Staelens, Filip Triest, Nina Van Goethem, Jens Van Praet, Anke Vanhoenacker, R. Verstraete, Elise Willems

2020International Journal of Antimicrobial Agents125 citationsDOIOpen Access PDF

Topics & Concepts

HydroxychloroquineMedicineHazard ratioConfidence intervalInternal medicineRetrospective cohort studyCoronavirus disease 2019 (COVID-19)Proportional hazards modelSurgeryDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Sepsis Diagnosis and Treatment